Posted inStock
WVE Stock Crashes 56% Today, Falls to $5 as Wave’s Obesity Drug Data Shocks Investors
Wave Life Sciences stock plunged 56% on Thursday, falling to around $5, after the company reported six-month data for its obesity candidate WVE-007 that showed only modest placebo-adjusted weight loss.…







